GE HealthCare Technologies Inc.

01/29/2026 | Press release | Distributed by Public on 01/29/2026 07:07

GE HealthCare receives FDA 510(k) clearance for MIM LesionID™ Pro, helping transform whole-body tumor burden analysis

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
GE HealthCare Technologies Inc. published this content on January 29, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 29, 2026 at 13:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]